Drugs / simplified LV5FU2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01964534 | Dec 2013 → Feb 2017 | malignant pancreatic neoplasm | GERCOR - Multidisciplinary Oncology Cooperative Group | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | simplified LV5FU2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01964534 ↗ |
| Route | Intravenous | “5-FU infusion: 2400 mg/m² IV /46h (day 1-2, day 15-16)” NCT01964534 ↗ |